Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis

Vaccine

Volumn 24, Issue 1, 2006, Pages 36-44

  Humphries, Holly E ^a   Williams, Jeannette N ^a   Blackstone, Ramona ^a   Jolley, Keith A ^a,b   Yuen, Ho M ^a   Christodoulides, Myron ^a   Heckels, John E ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Immunogenicity; Multivalent liposomes; Neisseria meningitides; Recombinant PorA

Indexed keywords

LIPOSOME; OUTER MEMBRANE PROTEIN; PORIN A; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION;

ANIMALS; ANTIBODIES, BACTERIAL; CROSS REACTIONS; IMMUNE SERA; LIPOSOMES; MENINGOCOCCAL VACCINES; MICE; MICE, INBRED BALB C; NEISSERIA MENINGITIDIS; PORINS; SEROTYPING; VACCINES, SYNTHETIC;

EID: 28344436617     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.07.056     Document Type: Article

References (49)

1. P. Balmer, R. Borrow, and E. Miller Impact of meningococcal C conjugate vaccine in the UK J Med Microbiol 51 2002 717 722
2. I. Idanpaan-Heikkila, E.A. Hoiby, P. Chattopadhyay, U. Airaksinen, T.M. Michaelsen, and E. Wedege Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease J Med Microbiol 43 1995 335 343
3. J. Finne, M. Leinonen, and P.H. Makela Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis Lancet ii 1983 355 357
4. E. Wedege, and L.O. Froholm Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting Infect Immun 51 1986 571 578
5. L.G. Milagres, S.R. Ramos, C.T. Sacchi, C.E.A. Melles, V.S.D. Vieira, and H. Sato Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy Infect Immun 62 1994 4419 4424
6. E. Rosenqvist, E.A. Hoiby, E. Wedege, K. Bryn, J. Kolberg, and A. Klem Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine Infect Immun 63 1995 4642 4652
7. E.M. Rouppe van der Voort, P. van der Ley, J. van der Biezen, S. George, O. Tunnela, and H. van Dijken Specificity of human bactericidal antibodies against PorA P1.7, 16 induced with a hexavalent meningococcal outer membrane vesicle vaccine Infect Immun 64 1996 2745 2751
8. P. van der Ley, J.E. Heckels, M. Virji, P. Hoogerhout, and J.T. Poolman Topology of outer membrane porins in pathogenic Neisseria spp Infect Immun 59 1991 2963 2971
9. B.T. McGuinness, P.R. Lambden, and J.E. Heckels Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology Mol Microbiol 7 1993 505 514
10. G. Bjune, E.A. Hoiby, J.K. Gronnesby, O. Arnesen, J. Holstfredriksen, and A. Halstensen Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway Lancet 338 1991 1093 1096
11. J. Boslego, J. Garcia, C. Cruz, W. Zollinger, B. Brandt, and S. Ruiz Efficacy, safety, and immunogenicity of a meningococcal group B (15 P1.3) outer membrane protein vaccine in Iquique, Chile Vaccine 13 1995 821 829
12. J.C. Demoraes, B.A. Perkins, M.C.C. Camargo, N.T.R. Hidalgo, H.A. Barbosa, and C.T. Sacchi Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil Lancet 340 1992 1074 1078
13. B.A. Perkins, K. Jonsdottir, H. Briem, E. Griffiths, B.D. Plikaytis, and E.A. Hoiby Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland J Infect Dis 177 1998 683 691
14. S.B. Carbonare, C. Arslanian, M.M. Silva, C.K. Farhat, and M.S. Carneirosampaio The antimeningococcal vaccine VA-MENGOC-BC induced poor serum and salivary antibody-response in young Brazilian children Pediatr Infect Dis J 14 1995 797 803
15. K. Sexton, D. Lennon, P. Oster, S. Crengle, D. Martin, and K. Mulholland The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic NZ Med J 117 2004 U1015
16. J. O'Hallahan, D. Lennon, P. Oster, R. Lane, S. Reid, and K. Mulholland From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease Vaccine 23 2005 2197 2201
17. P. van der Ley, J. van der Biezen, and J.T. Poolman Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine Vaccine 13 1995 401 407
18. I. Claassen, J. Meylis, P. van der Ley, C. Peeters, H. Brons, and J. Robert Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine Vaccine 14 1996 1001 1008
19. C.M. Peeters, H.C. Rumke, L.C. Sundermann, E.R. Vandervoort, J. Meulenbelt, and M. Schuller Phase-I clinical-trial with a hexavalent PorA containing meningococcal outer-membrane vesicle vaccine Vaccine 14 1996 1009 1015
20. K. Cartwright, R. Morris, H. Rumke, A. Fox, R. Borrow, and N. Begg Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins Vaccine 17 1999 2612 2619
21. C. Arigita, G.F.A. Kersten, T. Hazendonk, W.E. Hennink, D.J.A. Crommelin, and W. Jiskoot Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes Vaccine 21 2003 950 960
22. M. Christodoulides, J.L. Brooks, E. Rattue, and J.E. Heckels Immunisation with recombinant class 1 outer membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci Microbiology 144 1998 3027 3037
23. H.E. Humphries, J.N. Williams, M. Christodoulides, and J.E. Heckels Recombinant meningococcal PorA protein, expressed using a vector system with potential for human vaccination, induces a bactericidal immune response Vaccine 22 2004 1564 1569
24. I. Idanpaan-Heikkila, S. Muttilainen, E. Wahlstrom, L. Saarinen, M. Leinonen, and M. Sarvas The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis Vaccine 13 1995 1501 1508
25. C. Jansen, B. Kuipers, J. van der Biezen, H. de Cock, P. van der Ley, and J. Tommassen Immunogenicity of in vitro folded outer membrane protein PorA of Neisseria meningitidis FEMS Immunol Med Microbiol 27 2000 227 233
26. S. Muttilainen, I. Idanpaan-Heikkila, E. Wahlstrom, M. Nurminen, P.H. Makela, and M. Sarvas The Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis and reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes Microb Pathog 18 1995 423 436
27. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular cloning - a laboratory manual 2nd ed. 1989 Cold Spring Harbour Press, Cold Spring Harbour NY, USA
28. C.R. Tinsley, and J.E. Heckels Variation in the expression of pili and outer membrane protein by Neisseria meningitidis during the course of meningococcal infection J Gen Microbiol 132 1986 2483 2490
29. Meningococcal vaccines M. Christodoulides K. Jolley J.E. Heckels A.J. Pollard M.C.J. Maiden Recombinant proteins in vaccine development 2001 Humana Press Totowa, New Jersey 167 180
30. S.J. Ward, D.A. Scopes, M. Christodoulides, I.N. Clarke, and J.E. Heckels Expression of Neisseria meningitidis class 1 porin as a fusion protein in Escherichia coli: the influence of liposomes and adjuvants on the production of a bactericidal immune response Microb Pathog 21 1996 499 512
31. B.T. McGuinness, I.N. Clarke, P.R. Lambden, A.K. Barlow, J.T. Poolman, and D.M. Jones Point mutation in meningococcal porA gene associated with increased endemic disease Lancet 337 1991 514 517
32. M. Christodoulides, B.T. McGuinness, and J.E. Heckels Immunisation with synthetic peptides containing epitopes of the class 1 outer membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunisation with a cyclic peptide J Gen Microbiol 139 1993 1729 1738
33. G.R. Jones, J.N. Williams, M. Christodoulides, K. Jolley, and J.E. Heckels Lack of immunity in university students prior to an outbreak of serogroup C meningococcal infection J Infect Dis 181 2000 1172 1175
34. K. Jolley, L. Appleby, J.C. Wright, M. Christodoulides, and J.E. Heckels Immunisation with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci Infect Immun 69 2001 3809 3916
35. E.B. Kaczmarski Meningococcal disease in England and Wales: 1995 Commun Dis Rep CDR Rev 7 1997 R55 R59
36. J.E. Heckels, J.N. Fletcher, and M. Virji The potential protective effect of immunization with outer membrane protein I from Neisseria gonorrhoeae J Gen Microbiol 135 1989 2269 2276
37. E. de Kleijn, C. Vermont, B. Kuipers, C. Vermont, H. van Dijken, and H. Rumke Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine Vaccine 20 2001 352 358
38. J.C. Wright, J.N. Williams, M. Christodoulides, and J.E. Heckels Immunisation with recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis Infect Immun 70 2002 4028 4034
39. T.A. Luijkx, H. van Dijken, H.J. Hamstra, B. Kuipers, P. van der Ley, and L. van Alphen Relative immunogenicity of PorA subtypes in a multivalent Neisseria meningitidis vaccine is not dependent on presentation form Infect Immun 71 2003 6367 6371
40. C. Jansen, A. Wiese, L. Reubsaet, N. Dekker, H. de Cock, and U. Seydel Biochemical and biophysical characterization of in vitro folded outer membrane porin PorA of Neisseria meningitidis Biochim Biophys Acta 1464 2000 284 298
41. H.L. Qi, J.Y. Tai, and M.S. Blake Expression of large amounts of neisserial porin proteins in Escherichia coli and refolding of the proteins into native trimers Infect Immun 62 1994 2432 2439
42. J.P. Derrick, M.C.J. Maiden, and L.M. Feavers Crystal structure of a Fab fragment in complex with a meningococcal serosubtype antigen and a protein G domain J Mol Biol 293 1999 81 91
43. I. Idanpaan-Heikkila, E. Wahlstrom, S. Muttilainen, M. Nurminen, H. Kayhty, and M. Sarvas Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100 Vaccine 14 1996 886 891
44. C.L. Vermont, H.H. van Dijken, A.J. Kuipers, W.C.M. Keijzers, R. De Groot, and L. van Alphen Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine Infect Immun 71 2003 1650 1655
45. E.M. Rouppe van der Voort, H. van Dijken, B. Kuipers, J. van der Biezen, P. van der Ley, and J. Meylis Human B- and T-cell responses after immunisation with a hexavalent PorA meningocccal outer membrane vesicle vaccine Infect Immun 65 1998 5184 5190
46. S.C. Clarke, M.A. Diggle, P. Molling, M. Unemo, and P. Olcen Analysis of PorA variable region 3 in meningococci: implications for vaccine policy? Vaccine 21 2003 2468 2473
47. J.Z. Jordens, J.N. Williams, G.R. Jones, M. Christodoulides, and J.E. Heckels Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students Infect Immun 72 2004 6503 6510
48. B.T. McGuinness, A.K. Barlow, I.N. Clarke, J.E. Farley, E. Anilionis, and J.T. Poolman Deduced amino acid sequences of class 1 protein (porA) from 3 strains of Neisseria meningitides - synthetic peptides define the epitopes responsible for serosubtype specificity J Exp Med 171 1990 1871 1882
49. J. Newcome, K. Cartwright, S. Dyer, and J. McFadden Naturally occurring insertional inactivation of the porA gene of Neisseria meningitidis by integration of IS 1301 Mol Microbiol 30 1998 453 454